Takeda Pharmaceutical Company Limited
PROTEASOME INHIBITORS
Last updated:
Abstract:
The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
Status:
Application
Type:
Utility
Filling date:
14 Apr 2022
Issue date:
11 Aug 2022